{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:04:49Z","timestamp":1784736289487,"version":"3.55.0"},"reference-count":25,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Multicenter Clinical Research Project of Shanghai Jiao Tong University School of Medicine","award":["DLY201805"],"award-info":[{"award-number":["DLY201805"]}]},{"name":"AstraZeneca Investment China Co Ltd, Shanghai, China","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR3029B"],"award-info":[{"award-number":["SHDC2020CR3029B"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,5]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hyperkalaemia (HK) is a potentially life-threatening electrolyte imbalance associated with several adverse clinical outcomes and is common in patients with kidney failure. However, there is no evidence on the occurrence, recurrence and treatment of HK in patients on haemodialysis (HD) in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The HK Prevalence, Recurrence, and Treatment in Haemodialysis Study is a prospective, multicentre, observational, cohort study being conducted across 15\u201318 sites in China. Approximately 600 patients with end-stage kidney disease on HD are anticipated to be enrolled and will be followed up for 24 weeks. Patients will be in the long interdialytic interval (LIDI) at enrolment and will receive follow-up care every 4 weeks in LIDI for pre-dialysis and post-dialysis (at enrolment only) serum potassium measurements. To obtain pre-dialysis serum potassium levels in the short interdialytic interval (SIDI), a follow-up visit will be performed in the SIDI during the first week. Information on concomitant medications, blood gas analysis and biochemistry measurements will be obtained at enrolment and at each follow-up visit. The primary endpoint will be the proportion of patients experiencing HK (defined as serum potassium level &gt;5.0\u2009mmol\/L) at the study enrolment or during the 24-week follow-up. The key secondary endpoint will be the proportion of patients experiencing HK recurrence (defined as any HK event after the first HK event) within 1\u20136 months (if applicable) during the 24-week follow-up, including enrolment assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has been approved by Shanghai Jiaotong University School of Medicine, Renji Hospital Ethics Committee (2020-040). Other participating subcentres must also obtain ethics committee approval prior to the start of the study. The Good Clinical Practice regulations shall be strictly followed during the test implementation. Amendments to the protocol will be reviewed by the ethics committees. Written informed consent will be obtained from all participants before collection of any patient data and patient information. The findings of this study will be disseminated through peer-reviewed publications and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04799067\">NCT04799067<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-055770","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T12:05:55Z","timestamp":1640174755000},"page":"e055770","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K)"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04799067","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Zhaohui","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2804-4702","authenticated-orcid":false,"given":"Haijiao","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-505X","authenticated-orcid":false,"given":"Renhua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University People's Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanxi Bethune Hospital, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yangquan Coal Industry (Group) General Hospital, Yangquan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Taihe Hospital, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhou","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shenzhen People's Hospital, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinkai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaosheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojian","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wenzhou Central Hospital, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The first hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangzhou First People's Hospital, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Medical Affaires, AstraZeneca Investment China Co, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"2025121409014507000_11.12.e055770.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61601-9"},{"key":"2025121409014507000_11.12.e055770.2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","article-title":"Clinical management of hyperkalemia","volume":"96","author":"Palmer","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2025121409014507000_11.12.e055770.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.07.035"},{"key":"2025121409014507000_11.12.e055770.4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","article-title":"Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the dialysis outcomes and practice patterns study (DOPPS)","volume":"69","author":"Karaboyas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2025121409014507000_11.12.e055770.5","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13421","article-title":"Associations between serum potassium and adverse clinical outcomes: a systematic literature review","volume":"74","author":"Palaka","year":"2020","journal-title":"Int J Clin Pract"},{"key":"2025121409014507000_11.12.e055770.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2008.00455.x"},{"key":"2025121409014507000_11.12.e055770.7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04451206"},{"key":"2025121409014507000_11.12.e055770.8","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13489"},{"key":"2025121409014507000_11.12.e055770.9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/sdi.12588","article-title":"Twice-Weekly hemodialysis in China: can it be a better option for initiation or maintenance dialysis therapy?","volume":"30","author":"Yan","year":"2017","journal-title":"Semin Dial"},{"key":"2025121409014507000_11.12.e055770.10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000446"},{"key":"2025121409014507000_11.12.e055770.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp104"},{"key":"2025121409014507000_11.12.e055770.12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.ajkd.2015.02.322","article-title":"Dialysate and serum potassium in hemodialysis","volume":"66","author":"Hung","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025121409014507000_11.12.e055770.13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/sdi.12252","article-title":"Sailing between Scylla and Charybdis: the high serum K-low dialysate K quandary","volume":"27","author":"Labriola","year":"2014","journal-title":"Semin Dial"},{"key":"2025121409014507000_11.12.e055770.14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ekir.2020.02.1028","article-title":"Current management of hyperkalemia in patients on dialysis","volume":"5","author":"Bansal","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2025121409014507000_11.12.e055770.15","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/ndt\/gfx053","article-title":"Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey","volume":"32","author":"Rossignol","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2025121409014507000_11.12.e055770.16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000448341","article-title":"Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study","volume":"44","author":"Yusuf","year":"2016","journal-title":"Am J Nephrol"},{"key":"2025121409014507000_11.12.e055770.17","doi-asserted-by":"crossref","unstructured":"Bian J , Zuo L , Zhao H , et al . P0799EPIDEMIOLOGY and treatment pattern of hyperkalaemia among outpatients in China: a descriptive study using an administrative database in China. Nephrol Dial Transplant 2020;35.doi:10.1093\/ndt\/gfaa142.P0799","DOI":"10.1093\/ndt\/gfaa142.P0799"},{"key":"2025121409014507000_11.12.e055770.18","unstructured":"02-10-7259_DBH_Best-Practices-in-Managing-Hyperkalemia-in-CKD.pdf. Available: https:\/\/www.kidney.org\/sites\/default\/files\/02-10-7259_DBH_Best-Practices-in-Managing-Hyperkalemia-in-CKD.pdf [Accessed 29 Sep 2021]."},{"key":"2025121409014507000_11.12.e055770.19","doi-asserted-by":"crossref","unstructured":"Nakai S , Hanafusa N , Masakane I . An overview of regular dialysis treatment in Japan (as of 31 December 2012): overview of dialysis treatment in Japan 2012. Ther Apher Dial 2014:535\u2013602.","DOI":"10.1111\/1744-9987.12281"},{"key":"2025121409014507000_11.12.e055770.20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.8.1629"},{"key":"2025121409014507000_11.12.e055770.21","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12195"},{"key":"2025121409014507000_11.12.e055770.22","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07950718"},{"key":"2025121409014507000_11.12.e055770.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103313"},{"key":"2025121409014507000_11.12.e055770.24","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01150112"},{"key":"2025121409014507000_11.12.e055770.25","first-page":"397","article-title":"Cardiac rhythm disturbances in hemodialysis patients","volume":"4","author":"Sacher","year":"2018","journal-title":"JACC: Clinical Electrophysiology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-055770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:01:56Z","timestamp":1765731716000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-055770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,22]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjopen-2021-055770"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-055770","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}